Head-To-Head Review: OptimizeRx (NASDAQ:OPRX) vs. Pro Medicus (OTCMKTS:PMCUF)

OptimizeRx (NASDAQ:OPRX) and Pro Medicus (OTCMKTS:PMCUF) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and price targets for OptimizeRx and Pro Medicus, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Pro Medicus	0	1	0	0	2.00

OptimizeRx currently has a consensus target price of $11.43, indicating a potential upside of 32.66%. Pro Medicus has a consensus target price of $155.00, indicating a potential upside of 16.02%. Given OptimizeRx’s stronger consensus rating and higher probable upside, equities research analysts plainly believe OptimizeRx is more favorable than Pro Medicus.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares OptimizeRx and Pro Medicus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Pro Medicus	N/A	N/A	N/A

Earnings & Valuation

This table compares OptimizeRx and Pro Medicus”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$98.65 million	1.64	$5.13 million	$0.23	37.46
Pro Medicus	N/A	N/A	N/A	N/A	N/A

OptimizeRx has higher revenue and earnings than Pro Medicus.

Summary

OptimizeRx beats Pro Medicus on 9 of the 9 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Pro Medicus

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.